Concepedia

Publication | Open Access

Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial

482

Citations

25

References

2017

Year

References

YearCitations

Page 1